Inactive Instrument
Pandion Therapeutics, Inc. Share Price
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 01/08/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/21 | Tender | Director | 91,738 | 0.3108% | ||
| 01/04/21 | Polaris Growth Management LLC
| Tender | Company | 32,01,422 | 10.8465% | |
| 01/04/21 | Tender | Executive/Senior Manager | 1,89,780 | 0.6430% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 170.43Cr | |
| +0.21% | -7.67% | +61.07% | +71.32% | 6.89TCr | |
| +1.66% | -9.54% | +10.39% | +60.04% | 5.19TCr | |
| +3.14% | +4.61% | +15.36% | +44.42% | 4.87TCr | |
| +3.45% | +5.01% | +32.37% | +35.96% | 4.31TCr | |
| -2.20% | -5.78% | +298.44% | +532.76% | 4.15TCr | |
| +6.43% | +2.76% | +16.56% | +109.23% | 4TCr | |
| +1.28% | -0.76% | +12.67% | +45.10% | 3.06TCr | |
| -2.21% | -14.22% | +40.33% | -0.94% | 2.6TCr | |
| +1.74% | -5.30% | -12.09% | -12.92% | 2.23TCr | |
| Average | +1.36% | -3.90% | +52.79% | +98.33% | 4.14TCr | |
| Weighted average by Cap. | +1.55% | -3.49% | +56.57% | +105.30% |
Employees
56
